NCT02997995 Durvalumab and Endocrine Therapy in ER+/Her2- Breast Cancer After CD8+ Infiltration Effective Immune-Attractant Exposure Status COMPLETED Phase PHASE2
NCT02995980 Study of Dual-energy (DE) Contrast-enhanced (CE) Digital Mammography Status COMPLETED Phase NA
NCT02995772 Neoadjuvant Hormonal Therapy Compared to Neoadjuvant Chemotherapy in Stage IIIB/C and IV Breast Cancer Patients Status COMPLETED Phase PHASE3
NCT02994914 GEriatric Determinants of Curative RAdiotherapy Scheme Choice for Breast Cancer ELderly Patient Treatment Compliance and Tolerance Status TERMINATED Phase NA
NCT02994225 Axillary Reverse Mapping Using Near-infrared Imaging in Invasive Breast Cancer: Predictors of Nodal Positivity Status COMPLETED Phase NA
NCT02988648 A Clinical Trial Evaluating the Safety and Clinical Activity of Radioiodide (131I-) as a Novel Targeted Therapy for Metastatic Breast Cancer That Overexpresses Functional Na/I Symporter Status WITHDRAWN Phase PHASE1/PHASE2
NCT02985073 A Comparison Between Biological (Veritas®) vs Non Biological Mesh (TIGR®) in Immediate Breast Reconstruction Status COMPLETED Phase NA
NCT02983071 G1T38, a CDK 4/6 Inhibitor, in Combination With Fulvestrant in Hormone Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer Status UNKNOWN Phase PHASE1/PHASE2
NCT02982421 The Effect of Art Therapy on Physical and Psychological Symptoms of Breast Cancer Survivors Status UNKNOWN Phase NA
NCT02980848 Assessing Breast Density's Value in Imaging - A Comparative Effectiveness Study Status UNKNOWN Phase N/A
NCT02978716 Trilaciclib (G1T28), a CDK 4/6 Inhibitor, in Combination With Gemcitabine and Carboplatin in Metastatic Triple Negative Breast Cancer (mTNBC) Status TERMINATED Phase PHASE2
NCT02978586 A Pilot Study of [Ga-68]PSMA PET/MRI for the Assessment of PSMA-positive Tumors Status COMPLETED Phase N/A
NCT02970786 Phase I Trial: 68Ga-NODAGA-E(c[RGDyK])2 Positron Emission Tomography for Imaging Angiogenesis in Primary and Metastatic Tumor Lesions in Humans Status UNKNOWN Phase PHASE1
NCT02969291 A Home-Based Study to Enhance Activity in Breast Cancer Survivors Status COMPLETED Phase NA
NCT02960594 hTERT Immunotherapy Alone or in Combination With IL-12 DNA Followed by Electroporation in Adults With Solid Tumors at High Risk of Relapse Status COMPLETED Phase PHASE1
NCT02958852 A Clinical Trial to Compare Efficacy and Tolerability of Atorvastatin in Addition to Endocrine Treatment With Focus on Mechanisms of Resistance to Endocrine Treatment (Fulvestrant/Aromatase Inhibitors) in Patients With Advanced Breast Cancer Status COMPLETED Phase PHASE2
NCT02958774 Hypofractionated Radiation Therapy for Patients With Breast Cancer Receiving Regional Nodal Irradiation Status ACTIVE_NOT_RECRUITING Phase NA
NCT02956473 Supine MRI in Breast Cancer Patients Undergoing Upfront Surgery or Receiving Neoadjuvant Therapy Status COMPLETED Phase NA
NCT02955940 An Open-Label Study to Enable Continued Treatment Access for Subjects Previously Enrolled in Studies of Ruxolitinib Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT02955394 Preoperative Fulvestrant With or Without Enzalutamide in ER+/Her2- Breast Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE2